Status:
COMPLETED
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
Yale University
Conditions:
Opioid-Related Disorders
Substance-Related Disorders
Eligibility:
All Genders
21-55 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess optimal dosage of buprenorphine on a thrice weekly schedule in a pilot clinical trial.
Eligibility Criteria
Please contact site for information.
Key Trial Info
Start Date :
December 1 1994
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
202 Patients enrolled
Trial Details
Trial ID
NCT00000318
Start Date
December 1 1994
End Date
August 1 2007
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
APT Residential Services Division
New Haven, Connecticut, United States, 06519